CONTENTS

        Chapters
  1. Research and Regulatory Approval
  2. Use of Injectables
  3. Effectiveness and Reversibility
  4. Side Effects and Complications
  5. More Evidence in the Cancer Debate
  6. Noncontraceptive Health Benefits
  7. Counseling Issues
  8. Communicating with the Public
  9. Maximizing Access and Quality

Published with this issue:

HIGHLIGHTS


Published by the Population Information Program, Center for Communication Programs, The Johns Hopkins School of Public Health, 111 Market Place, Suite 310, Baltimore, Maryland 21202-4012, USA

Volume XXIII, Number 2 August 1995

Return to Fertility

No woman should use DMPA or NET EN without knowing that she may have to wait to become pregnant after stopping. Providers may simply say that pregnancy may be delayed for several months. If women want to know how long they may have to wait, providers have several options for describing the typical delay:

  • Time from last injection: Half of DMPA users become pregnant in the first nine months after the last injection, and half wait longer.
  • Time from when the next injection would have been given—six months, on average, for DMPA.
  • Compared with other methods: DMPA users may have to wait two to three months longer on average than former OC users.
In any case, providers need to make clear that time to conception cannot be predicted for any woman.

Returning Late or Early

Programs in Guatemala, Indonesia, Jamaica, Kenya, and other countries report that the vast majority of clients return on time for their injections (48, 127, 188). Many programs help clients return on time by giving them an appointment card. In Indonesia, for example, providers write the date of the next injection on a family planning identification card that the client keeps, and providers are encouraged to remind clients twice during counseling of the specific day to return (188).

To ensure informed choice, providers should tell clients that they may return late or early for an injection and still be protected against pregnancy. Without this information, clients may assume that they have no choice but to return on a specific day. If they miss an appointment, they may assume that they cannot get another injection, and they may discontinue use (167). Providers may tell women, however, that if they have not returned by the end of the grace period and it is not reasonably certain that they are not pregnant, they may need a pregnancy test or to wait for their next menstrual period before they can get another injection. They should use condoms or another barrier method until then. In areas with reliable telephone service, some providers do not tell users about the grace period unless users call to say that they cannot come on the scheduled day.

Providers should not tell clients that the grace period is shorter than it actually is. Once users find out the truth, they may distrust providers. Studies are needed to assess the effect of information about the grace period on clients' adherence to the injection schedule.

Clients who are often late can be given appointments earlier than usual—for example, after 2 months and three weeks for DMPA rather than the full 3-month interval. Providers should try to determine why clients are late—for example, they may fear getting an injection or they may have trouble getting to the clinic—and help them to overcome any problems (116).


Previous | Next
Top of Page | Table of Contents


111 Market Place, Suite 310, Baltimore, MD 21202, USA
Phone: (410) 659.6300/Fax: (410) 659.6266/E-mail: Poprepts@jhuccp.org

Population Reports